Fundamental Analysis
44 / 100BRubric: Manufacturing
| Quarterly results | Relative Valuation | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Criterion | Latest Q EPS growth (YoY) | Avg EPS growth, last 3 (YoY) | Quarters with EPS growth | Revenue growth (YoY) | Gross margin change (pp, YoY) | Net margin change (pp, YoY) | Return on Equity (TTM) | Financial health (Debt/Equity) | Valuation (P/E vs 5-yr median) | Revenue (bn) | Rev YoY | NPAT (bn) | NPAT YoY | P/E | 5-Year Median P/E | P/E vs. 5-Year Median |
| Value | +16.9% | +25.0% | 2 / 3 | -5.7% | +1.28 pp | +2.24 pp | +11.2% | 0.00 | 11.18 | 760 | −5,7% | 88,5 | +16,9% | 11.18 | 13.73 | −18,6% |
| Pts | 0 | 0 | 8 | 0 | 8 | 12 | 0 | 12 | 8 | |||||||
Valuation annotation:Price: 26.500 (close price on 2026-10-19)EPS (TTM): 2.371
Financial charts
1.Revenue & growth
VND bn760Q2/26
1.Revenue & growth
VND bn760Q2/26
2.Profit & growth
VND bn88,5Q2/26
3.Profit mix (Penman)
VND bn296Q2/26
4.Margins & cost structure
%29.3%Q2/26
5.Returns & cash cycle
% · days19.2%Q2/26
6.Earnings quality & cash
VND bn235Q2/26
7.Asset structure
VND bn2.654Q2/26
8.Funding & debt health
VND bn · times2.654Q2/26
9.Revenue backlog
VND bn2,59Q2/26
10.Valuation
times · %11,2×Q2/26
11.EPS growth & dilution warning (CANSLIM)
VND per share; growth in %805Q2/26
Adjusted EPS growth, latest quarter
16.9%
Average adjusted EPS growth, 3 quarters
25.0%
Quarters at 25%+ growth
1/3
Share dilution rate, 1 year
0.0%
Source: vnstockData through Q2/26